Immtech Pharmaceuticals Inc, formerly dba as Immtech International, Inc. is a biopharmaceutical company focused on the discovery and commercialization of therapeutics for the treatment of patients afflicted with opportunistic infectious diseases, cancer or compromised immune systems such as HIV infected persons. The Company has a pharmaceutical and a biological program for developing drugs. The pharmaceutical program is based on a technology platform for the design of a class of pharmaceutical compounds referred to as dications. The biological program for developing drugs is based on biological proteins that work in conjunction with the body's immune system. These biological proteins are derivatives of C-Reactive Protein (CRP).
